Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension

Table 1

Patient characteristics.

	TIPS	OCT-LAR
Patients (M/F)	9/3	8/4	0.65
Age (years)	49.6 ± 8.7	50.8 ± 9.8	0.76
Child scores	8.1 ± 0.5	8.0 ± 0.6	0.72
Chronic active hepatitis/alcoholic cirrhosis	9/3	9/3	1.0
Follow-up time (d)	79.2 ± 19.9	82.1 ± 16.8	0.69